Lv21
102 积分 2025-07-18 加入
Antibiotic-induced gut dysbiosis and barrier disruption and the potential protective strategies
2小时前
待确认
Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial
3天前
已完结
Pharmacodynamics and Pharmacokinetics of the Potassium-Competitive Acid Blocker Vonoprazan and the Proton Pump Inhibitor Lansoprazole in US Subjects
3天前
已完结
Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis
6天前
已完结
Efficacy and safety of fexuprazan in patients with symptoms and signs of laryngopharyngeal reflux disease: a randomized clinical trial
10天前
已完结
Randomised phase 3 trial: tegoprazan, a novel potassium‐competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis
10天前
已完结
Saliva Pepsin Detection and Proton Pump Inhibitor Response in Suspected Laryngopharyngeal Reflux
10天前
已完结
Eight weeks of omeprazole 20 mg significantly reduces both laryngopharyngeal reflux and comorbid chronic rhinosinusitis signs and symptoms: Randomised, double‐blind, placebo‐controlled trial
10天前
已完结
The Dubai Definition and Diagnostic Criteria of Laryngopharyngeal Reflux: The IFOS Consensus
10天前
已完结
Lansoprazole Treatment of Patients With Chronic Idiopathic Laryngitis: A Placebo-Controlled Trial
10天前
已完结
皖公网安备34019202002308
